Stockreport

Kaida BioPharma Appoints Co-Founder Dr. Stella K. Vnook as Chairperson of the Board [Yahoo! Finance]

Enveric Biosciences, Inc.  (ENVB) 
PDF Company advancing KAD-101, a best-in-class, next-generation prolactin receptor antagonist, toward a Phase 1 clinical study FORT LAUDERDALE, FL, Jan. 22, 2026 (GLOBE N [Read more]